论文部分内容阅读
非小细胞肺癌(non-small cell lung cancer,NSCLC)局部淋巴结(N)分期是影响患者治疗方案选择的关键因素之一。目前临床所使用的无创和有创性N分期方法均有其局限性。研究发现NSCLC的某些影像学特点可预测淋巴结转移的危险性,包括大小、CT密度和氟代脱氧葡萄糖(uorodeoxyglucose,FDG)标准化摄取值(standard-ized uptake value,SUV)等。期待系统性多因素分析,以发现影响肺癌淋巴结转移的关键因素。
Local lymph node (N) staging in non-small cell lung cancer (NSCLC) is one of the key factors affecting the choice of treatment options. Currently used in clinical non-invasive and invasive N staging methods have their limitations. Some of the imaging features of NSCLC have been shown to predict the risk of lymph node metastases, including size, CT density, and standard-ized uptake value (SUV) of fluorodeoxyglucose (FDG). Look forward to systematic multivariate analysis to find the key factors affecting lymph node metastasis in lung cancer.